alexa Abstract | Metal Ion Complex -Potential Anticancer Drug- A Review


Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access

Abstract

Many metal-containing compounds have been utilized throughout history to treat a wide variety of disorders. In medicinal chemistry —traditionally dominated by organic chemistry— metal complexes have gained favor as diagnostic tools and anticancer agents. Cancer is the second most frequent cause of death in the world. The discovery of antitumor activity of cisplatin began a search for other metal complexes with cytotoxic properties against cancer cells. Organo-metallic compounds have been used in medicine for centuries. Metal complexes play essential role in pharmaceutical industry and in agriculture. The metallo-elements present in trace quantities play vital roles at the molecular level in living system. The transition metal ions are responsible for proper functioning of different enzymes. Transition metals represent the D block element which includes groups 3 - 12 on the periodic table. Their d shells are in process of filling. The partially filled d orbital in transition metals impart interesting electronic properties that can act as suitable probes in the design of anticancer agents. This property of transition metals resulted in the foundation of coordination complexes. In 1960 the anti-tumor activity of an inorganic complex cis-diammine-dichloroplatinum (II) (cisplatin) was discovered. Cisplatin has developed into one of the most frequently used and most effective drug for treatment of solid carcinomas. This review focuses on recent advances in development of platinum, gold, copper and ruthenium complexes as anticancer agents.

To read the full article Peer-reviewed Article PDF image

Author(s): Baile M. B., Kolhe N. S., Deotarse P. P., Jain A. S., Kulkarni A. A.

Keywords

Anticancer drugs, metal ion complex, transition metal compound, Cancer Diagnosis,Tumor Immunobiology ,Cancer Screening,Alternative Cancer Medicines,Cancer Prevention from Nuts,Cancer Pathology

Recommended Journals

Share This Page

Additional Info

Loading
Loading Please wait..
 
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords